Home > Offer to Sell > Intermediates > Pharmaceutical intermediates > Lisinopril CAS 83915-83-7 (jerryzhang001@chembj.com)
Lisinopril CAS 83915-83-7 (jerryzhang001@chembj.com)
Inquiry
Post Date: | Apr 20,2017 |
Expiry Date: | Apr 20,2018 |
Detailed Description: |
Cas No. :83915-83-7
Payment Method: T/T; Western Union; Moneygram and Bitcoin Lisinopril CAS 83915-83-7 Product Name: Lisinopril; Synonyms: LISINOPRIL-D5 HYDRATE;LISINOPRIL HYDRATE;(ds)-1-[n2-(1-carboxy-3-phenylpropyl)-l-prolinedihydrate;(s)-1-(n(sup2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-l-prolinedihydrate;1-(n(sup2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-,dihydrate,(s)-l-prolin;renacor;N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]5-methylpyrazinecarboxamide dihydrate;Lisinopril dihydrate USP24,25 EP2000(III); CAS: 83915-83-7; MF: C21H31N3O5; MW: 405.49; EINECS: 278-488-1; Product Categories: Drug bulk;Active Pharmaceutical Ingredients;All Inhibitors;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API's;Angiotensin;ZESTRIL;Cardiovascular APIs; Melting point: 148 °C; refractive index: -45 ° (C=1, 0.25mol/L Zinc Acetate Buffer); storage temp.: 2-8°C; Chemical Properties: White to Off-White Crystalline Powder; Usage: An orally active angiotensin-converting enzyme (ACE) inhibitor. S,S,S-Isomer of Lisinopril; Description: Lisinopril is a drug of the angiotensin-converting enzyme (ACE) inhibitor class used primarily in treatment of high blood pressure, heart failure, and after heart attacks. It is also used for preventing kidney and eye complications in people with diabetes. Its indications, contraindications, and side effects are as those for all ACE inhibitors. Lisinopril was the third ACE inhibitor (after captopril and enalapril) and was introduced into therapy in the early 1990s. A number of properties distinguish it from other ACE inhibitors: It is hydrophilic, has a long half-life and tissue penetration, and is not metabolized by the liver. Medical Usage: Lisinopril is typically used for the treatment of hypertension, congestive heart failure, acute myocardial infarction, and diabetic nephropathy. |
CAS Registry Number: | 83915-83-7 |
Synonyms: | ;N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]5-methylpyrazinecarboxamide dihydrate;N~2~-(1-carboxy-3-phenylpropyl)-L-lysyl-L-proline dihydrate;N~2~-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline dihydrate; |
Molecular Formula: | C21H31O5N3·2(H2O) |
Molecular Weight: | 441.5185 |
Molecular Structure: | |
Safety Description: | S22:; S24/25:; |
Company: | Nanjing Bangnuo Biotechnology Co., Ltd. [ China ] |
Contact: | Jerry Zhang |
Tel: | 86-25-52198306 |
Fax: | |
Email: | jerryzhang001@chembj.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.